{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:25:43Z","timestamp":1784845543599,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":52,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Migration and Health"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.jmh.2024.100217","type":"journal-article","created":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T06:24:52Z","timestamp":1708842292000},"page":"100217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Risk of vaccine preventable diseases in UK migrants: A serosurvey and concordance analysis"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9946-2509","authenticated-orcid":false,"given":"Mayuri","family":"Gogoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Wiselka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judi","family":"Gardener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Renals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Lewszuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hargreaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmh.2024.100217_bib0001","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/vaccines8010066","article-title":"Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy","volume":"8","author":"Anichini","year":"2020","journal-title":"Vaccines."},{"key":"10.1016\/j.jmh.2024.100217_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062894","article-title":"We don't routinely check vaccination background in adults\u201d: a national qualitative study of barriers and facilitators to vaccine delivery and uptake in adult migrants through UK primary care","volume":"12","author":"Carter","year":"2022","journal-title":"BMJ Open."},{"issue":"10299","key":"10.1016\/j.jmh.2024.100217_bib0003","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0140-6736(21)01337-4","article-title":"Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study","volume":"398","author":"Causey","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.jmh.2024.100217_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00066-4","article-title":"Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review","author":"Crawshaw","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"12","key":"10.1016\/j.jmh.2024.100217_bib0005","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1016\/S1473-3099(21)00193-6","article-title":"Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review","volume":"21","author":"Deal","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jmh.2024.100217_bib0006","article-title":"Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: a national qualitative interview study to explore the views of undocumented migrants, asylum seekers, and refugees","volume":"4","author":"Deal","year":"2021","journal-title":"J. Migr. Health"},{"key":"10.1016\/j.jmh.2024.100217_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(22)00089-5","article-title":"Immunisation status of UK-bound refugees between January 2018, and October 2019: a retrospective, population-based cross-sectional study","author":"Deal","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jmh.2024.100217_bib0008","doi-asserted-by":"crossref","first-page":"taad084","DOI":"10.1093\/jtm\/taad084","article-title":"Defining drivers of under-immunisation and vaccine hesitancy in refugee and migrant populations to support strategies to strengthen uptake of COVID-19 vaccines: a rapid review","author":"Deal","year":"2023","journal-title":"J. Travel. Med."},{"key":"10.1016\/j.jmh.2024.100217_bib0009","unstructured":"European Centre for Disease Prevention and Control (ECDC). Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU\/EEA. Stockholm: ECDC. 2018. Accessed from https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Public%20health%20guidance%20on%20screening%20and%20vaccination%20of%20migrants%20in%20the%20EU%20EEA.pdf> in Sep 2022."},{"key":"10.1016\/j.jmh.2024.100217_bib0010","unstructured":"European Centre for Disease Prevention and Control (ECDC). Communicable disease threats report. Week 24, 11\u2212 17 June 2023, Stockholm: ECDC. Accessed from https:\/\/www.ecdc.europa.eu\/en\/publications-data\/communicable-disease-threats-report-11-17-june-2023-week-24 on 5th July 2023."},{"issue":"12","key":"10.1016\/j.jmh.2024.100217_bib0011","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.vaccine.2018.01.079","article-title":"Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands","volume":"36","author":"Freidl","year":"2016","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.jmh.2024.100217_bib0012","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1016\/j.vaccine.2019.06.068","article-title":"Immunisation of migrants in EU\/EEA countries: policies and practices","volume":"37","author":"Giambi","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jmh.2024.100217_bib0016","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.vaccine.2017.12.041","article-title":"IgG antibody prevalence suggests high immunization needs in newcomers to Luxembourg","volume":"36","author":"H\u00fcbschen","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jmh.2024.100217_bib0013","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/23744235.2018.1524583","article-title":"Measles and rubella seroimmunity in newly arrived adult immigrants in Sweden","volume":"51","author":"Hagstam","year":"2019","journal-title":"Infect Dis"},{"issue":"1","key":"10.1016\/j.jmh.2024.100217_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/jms.2009.008080","article-title":"Rubella seroprevalence in pregnant women in North Thames: estimates based on newborn screening samples","volume":"16","author":"Hardelid","year":"2009","journal-title":"J. Med. Screen."},{"issue":"41","key":"10.1016\/j.jmh.2024.100217_bib0015","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700772","article-title":"on behalf of the ESGITM working group on vaccination in Migrants. Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017","volume":"23","author":"Hargreaves","year":"2018","journal-title":"Eurosurveillance"},{"issue":"13","key":"10.1016\/j.jmh.2024.100217_bib0017","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.vaccine.2020.02.025","article-title":"Are refugees arriving in Denmark an under-immunised group for measles? A cross-sectional serology study","volume":"38","author":"Hvass","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.jmh.2024.100217_bib0018","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s15010-016-0926-7","article-title":"Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015","volume":"44","author":"Jablonka","year":"2016","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.jmh.2024.100217_bib0019","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40121-017-0169-7","article-title":"Measles, rubella and varicella IgG seroprevalence in a large refugee cohort in Germany in 2015: a cross-sectional study","volume":"6","author":"Jablonka","year":"2017","journal-title":"Infect. Dis. Ther."},{"issue":"12","key":"10.1016\/j.jmh.2024.100217_bib0020","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1080\/21645515.2018.1496766","article-title":"Mandatory and recommended vaccinations in Poland in the views of parents","volume":"14","author":"Kra\u015bnicka","year":"2018","journal-title":"Hum. Vaccin. ImmunOther"},{"issue":"3","key":"10.1016\/j.jmh.2024.100217_bib0021","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jiac.2013.10.006","article-title":"Self-reported histories of disease and vaccination against measles, mumps, rubella and varicella in health care personnel in Japan","volume":"20","author":"Kumakura","year":"2014","journal-title":"J. Infect. Chemother."},{"issue":"11","key":"10.1016\/j.jmh.2024.100217_bib0022","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1080\/21645515.2015.1096457","article-title":"Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations","volume":"11","author":"Lam","year":"2015","journal-title":"Hum. Vaccin. ImmunOther"},{"issue":"2","key":"10.1016\/j.jmh.2024.100217_bib0024","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/20477724.2017.1281374","article-title":"Vaccinations in migrants and refugees: a challenge for European health systems: a systematic review of current scientific evidence","volume":"111","author":"Mipatrini","year":"2017","journal-title":"Pathog. Glob. Health"},{"issue":"12","key":"10.1016\/j.jmh.2024.100217_bib0023","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/cid\/ciab079","article-title":"The impact of vaccination on coronavirus disease 2019 (COVID-19) Outbreaks in the United States","volume":"73","author":"Moghadas","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jmh.2024.100217_bib0025","doi-asserted-by":"crossref","first-page":"taab025","DOI":"10.1093\/jtm\/taab025","article-title":"Seroprevalence of vaccine-preventable and non-vaccine-preventable infections in migrants in Spain","volume":"28","author":"Norman","year":"2021","journal-title":"J. Travel. Med."},{"key":"10.1016\/j.jmh.2024.100217_bib0026","unstructured":"ONS. How life has changed in Leicester: census 2021. Published 2023. Available from https:\/\/www.ons.gov.uk\/visualisations\/censusareachanges\/E06000016\/."},{"key":"10.1016\/j.jmh.2024.100217_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-056591","article-title":"et alCOVID-19 vaccine hesitancy among undocumented migrants during the early phase of the vaccination campaign: a multicentric cross-sectional study","volume":"12","author":"Page","year":"2022","journal-title":"BMJ Open."},{"issue":"3","key":"10.1016\/j.jmh.2024.100217_bib0028","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/vaccines11030680","article-title":"Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era","volume":"11","author":"Perry","year":"2023","journal-title":"Vaccines. (Basel)"},{"issue":"2","key":"10.1016\/j.jmh.2024.100217_bib0029","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/vaccines8020218","article-title":"Are the objectives proposed by the who for routine measles vaccination coverage and population measles immunity sufficient to achieve measles elimination from Europe?","volume":"8","author":"Plans-Rubi\u00f3","year":"2020","journal-title":"Vaccines. (Basel)"},{"key":"10.1016\/j.jmh.2024.100217_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2021.03.008","article-title":"Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study","volume":"94","author":"Robertson","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jmh.2024.100217_bib0031","unstructured":"Saliba, V. Measles has been eliminated in the UK \u2013 so why do we still see cases and outbreaks? 22nd Jan 2018. UKHSA Blog. Available at https:\/\/ukhsa.blog.gov.uk\/2018\/01\/22\/measles-has-been-eliminated-in-the-uk-so-why-do-we-still-see-cases-and-outbreaks\/."},{"issue":"8","key":"10.1016\/j.jmh.2024.100217_bib0032","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1017\/S0950268807008497","article-title":"The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK","volume":"135","author":"Talukder","year":"2007","journal-title":"Epidemiol Infect."},{"issue":"7","key":"10.1016\/j.jmh.2024.100217_bib0033","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/ijerph13070650","article-title":"Seroprevalence of antibodies against measles, rubella and varicella among asylum seekers arriving in lower Saxony, Germany","volume":"13","author":"Toikkanen","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"5","key":"10.1016\/j.jmh.2024.100217_bib0034","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/516657","article-title":"Immunity Against Infectious Diseases Predictive Value of Self-Reported History of Vaccination and Disease","volume":"28","author":"Trevisan","year":"2007","journal-title":"Infect. Con. Hospital Epidem."},{"key":"10.1016\/j.jmh.2024.100217_bib0035","unstructured":"UKHSA. UK measles and rubella elimination indicators and status. Updated 25 Oct 2022. Accessed from https:\/\/www.gov.uk\/government\/publications\/measles-and-rubella-elimination-uk\/uk-measles-and-rubella-elimination on 5th July 2023."},{"key":"10.1016\/j.jmh.2024.100217_bib0036","unstructured":"UKHSA. Vaccination of individuals with uncertain or incomplete immunisation status. London: Updated 17th March 2022. Accessed from https:\/\/www.gov.uk\/government\/publications\/vaccination-of-individuals-with-uncertain-or-incomplete-immunisation-status\/vaccination-of-individuals-with-uncertain-or-incomplete-immunisation-status in Sep 2022."},{"issue":"9","key":"10.1016\/j.jmh.2024.100217_bib0037","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jmh.2024.100217_bib0039","series-title":"Delivery of immunization services for refugees and migrants: technical guidance","year":"2019"},{"key":"10.1016\/j.jmh.2024.100217_bib0040","series-title":"Measles and rubella strategic framework 2021\u20132030","year":"2020"},{"key":"10.1016\/j.jmh.2024.100217_bib0041","doi-asserted-by":"crossref","unstructured":"World Health Organization (2020b). Immunization agenda 2030: a global strategy to leave no one behind. Accessed from https:\/\/www.who.int\/publications\/m\/item\/immunization-agenda-2030-a-global-strategy-to-leave-no-one-behind on 5th July 2023.","DOI":"10.1016\/j.vaccine.2022.11.042"}],"container-title":["Journal of Migration and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666623524000072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666623524000072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T19:46:20Z","timestamp":1731440780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666623524000072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":40,"alternative-id":["S2666623524000072"],"URL":"https:\/\/doi.org\/10.1016\/j.jmh.2024.100217","relation":{},"ISSN":["2666-6235"],"issn-type":[{"value":"2666-6235","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of vaccine preventable diseases in UK migrants: A serosurvey and concordance analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Migration and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmh.2024.100217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100217"}}